Last checked at 2 Feb 2015 16:04
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades6,322
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,799.50
Bid:
1,796.00
Ask:
1,796.50
Change:
19.00 (1.07%)
Spread:
0.50 (0.028%)
Open:
1,784.00
High:
1,799.50
Low:
1,780.00
Prev. Close:
1,780.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.2 Feb 2015 06:15
30 Jan 2015 15:05
30 Jan 2015 06:16
29 Jan 2015 22:17
RPT-FEATURE-As smokers spark up e-cigs to quit, traditional aids suffer
(Repeats with no changes to text) By Jilian Mincer NEW YORK, Jan 29 (Reuters) - When Marty Weinstein decided to quit smoking, he took a friend's advice and tried electronic cigarettes rather than government-approved nicotine replacement products. Weinstein, 58, has gone from a p
Read more29 Jan 2015 15:56
29 Jan 2015 06:15
29 Jan 2015 06:00
FEATURE-As smokers spark up e-cigs to quit, traditional aids suffer
By Jilian Mincer NEW YORK, Jan 29 (Reuters) - When Marty Weinstein decided to quit smoking, he took a friend's advice and tried electronic cigarettes rather than government-approved nicotine replacement products. Weinstein, 58, has gone from a pack a day nine months ago to the equival
Read more29 Jan 2015 06:00
RPT-FEATURE-As smokers spark up e-cigs to quit, traditional aids suffer
(Repeats with no changes to text) By Jilian Mincer NEW YORK, Jan 29 (Reuters) - When Marty Weinstein decided to quit smoking, he took a friend's advice and tried electronic cigarettes rather than government-approved nicotine replacement products. Weinstein, 58, has gone from a p
Read more28 Jan 2015 18:21
EU mergers and takeovers (Jan 28)
BRUSSELS, Jan 28 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process: APPROVALS AND WITHDRAWALS -- Generic drugmaker Mylan Inc to purchase Abbot Laboratories' specialty and branded generics business outside the Unite
Read more28 Jan 2015 17:32
28 Jan 2015 17:28
UPDATE 1-EU clears plans by drugmakers GSK and Novartis to trade assets
* Plans win European Commission approval with conditions * Large companies try to focus on leading businesses (Recasts with oncology business, adds details) BRUSSELS, Jan 28 (Reuters) - The European Commission on Wednesday approved a plan by Novartis and GlaxoSmithKline to trade mor
Read more28 Jan 2015 16:34
RPT-EU clears GSK's acquisition of Novartis vaccines with conditions
(Repeats to distribute to more readers with no changes to text) BRUSSELS, Jan 28 (Reuters) - The European Commission said on Wednesday it had approved drugmaker GlaxoSmithKline's acquisition of Novartis' vaccines business, as well as a consumer healthcare joint venture between the two.
Read more28 Jan 2015 16:30
EU clears GSK's acquisition of Novartis vaccines with conditions
BRUSSELS, Jan 28 (Reuters) - The European Commission said on Wednesday it had approved drugmaker GlaxoSmithKline's acquisition of Novartis' vaccines business, as well as a consumer healthcare joint venture between the two. The companies agreed last April to trade more than $20 billion of a
Read more28 Jan 2015 16:30
EU clears Novartis to buy GSK's oncology business with conditions
BRUSSELS, Jan 28 (Reuters) - The European Commission said on Wednesday it had cleared the acquisition by Novartis of GSK oncology business subject to conditions. The Commission, the EU's executive arm, said its approval was conditional on the divestment of two of Novartis's cancer treatmen
Read more